Neurocrine Biosciences Inc (NAS:NBIX)
$ 136.53 -0.46 (-0.34%) Market Cap: 13.82 Bil Enterprise Value: 12.85 Bil PE Ratio: 36.60 PB Ratio: 5.08 GF Score: 88/100

Neurocrine Biosciences Inc at William Blair Biotech Focus Conference (Virtual) Transcript

Jul 15, 2021 / 04:00PM GMT
Release Date Price: $93.78 (-0.06%)
Myles Robert Minter
William Blair & Company L.L.C., Research Division - Analyst

Welcome back to the William Blair Biotech Focus Conference 2021. Thanks for joining us. My name is Myles Minter. I'm a senior biotech analyst here at the firm covering neurosciences among other areas.

Just before we get started for today's panel and neuropsychiatry updates, just have to refer listeners to disclosures on williamblair.com for various forward-looking statements that each company may be or may not be making in this chat.

Additionally, there is a link to a Q&A feature at the bottom of your screen. I'm already seeing a couple of pop-up, but feel free to type in your questions at the bottom there, and we'll do our best to get those answered around the panel.

But with that, it's my pleasure to welcome the panel members. Today we have representatives from Neurocrine, Praxis Precision Medicines, VistaGen and Aptinyx. I will not go through the introductions. Rather I'll have them introduce themselves and give a brief 1-minute spill on the exciting things that are happening at each

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot